10-Q Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643 Q2 2020

Filing Information

Form Type	10-Q
Accession Number	`0001213900-20-021649`
Period End Date	20200630
Filing Date	20200812
Fiscal Year	2020
Fiscal Period	Q2
XBRL Instance	rlmd-20200630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 59 Income Statement 46 Cash Flow Statement 53 Stockholders Equity 30

Balance Sheet 59 line items

Line Item	Tag	Value	Unit	Period
Preferred stock par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.22M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.43M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$13.82M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$36.28M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$80.16M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$120.26M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Common stock par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Lease payments receivable short term	`LeaseIncentiveReceivableCurrent`	$73.09K	USD	Point-in-time
Lease payments receivable short term	`LeaseIncentiveReceivableCurrent`	$76.21K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$423.86K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$240.53K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$134.40M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$116.94M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	15.85M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	14.46M	shares	Point-in-time
Fixed assets, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$2.94K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	14.46M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	15.85M	shares	Point-in-time
Fixed assets, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$5.01K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$25.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$25.00K	USD	Point-in-time
Lease payments receivable long term	`LeaseIncentiveReceivableNoncurrent`	$126.94K	USD	Point-in-time
Lease payments receivable long term	`LeaseIncentiveReceivableNoncurrent`	$165.83K	USD	Point-in-time
Total assets	`Assets`	$117.14M	USD	Point-in-time
Total assets	`Assets`	$134.56M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$522.66K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$965.17K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.36M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$824.94K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$110.25K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.33M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.46M	USD	Point-in-time
Preferred stock	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value, 50,000,000 shares authorized, 15,851,853 and 14,457,013 shares issued and outstanding, respectively	`CommonStockValue`	$14.46K	USD	Point-in-time
Common stock, $0.001 par value, 50,000,000 shares authorized, 15,851,853 and 14,457,013 shares issued and outstanding, respectively	`CommonStockValue`	$15.85K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$235.52M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$273.87M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-141.65M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-119.86M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$113.16M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$132.23M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.43M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$7.61M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$115.68M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$473.90K	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$117.14M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$134.56M	USD	Point-in-time

Income Statement 46 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$4.35M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$3.07M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$9.83M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$5.32M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$12.90M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.07M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$7.43M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.49M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$12.76M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$6.84M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$22.73M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$4.14M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-22.73M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-6.84M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-4.14M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-12.76M	USD	1 Quarter
Interest/investment income, net	`InvestmentIncomeInterestAndDividend`	$29.05K	USD	2 Qtrs
Interest/investment income, net	`InvestmentIncomeInterestAndDividend`	$811.66K	USD	2 Qtrs
Interest/investment income, net	`InvestmentIncomeInterestAndDividend`	$13.11K	USD	1 Quarter
Interest/investment income, net	`InvestmentIncomeInterestAndDividend`	$404.00K	USD	1 Quarter
Realized gain (loss) on short-term investments	`RealizedLossOnShorttermInvestments`	-	USD	1 Quarter
Realized gain (loss) on short-term investments	`RealizedLossOnShorttermInvestments`	$-12.81K	USD	1 Quarter
Realized gain (loss) on short-term investments	`RealizedLossOnShorttermInvestments`	$158.80K	USD	2 Qtrs
Realized gain (loss) on short-term investments	`RealizedLossOnShorttermInvestments`	-	USD	2 Qtrs
Unrealized gain on short-term investments	`UnrealizedLossOnShorttermInvestment`	$-1.22M	USD	1 Quarter
Unrealized gain on short-term investments	`UnrealizedLossOnShorttermInvestment`	-	USD	2 Qtrs
Unrealized gain on short-term investments	`UnrealizedLossOnShorttermInvestment`	$-287.03K	USD	2 Qtrs
Unrealized gain on short-term investments	`UnrealizedLossOnShorttermInvestment`	-	USD	1 Quarter
Total other (expenses) income	`NonoperatingIncomeExpense`	$939.88K	USD	2 Qtrs
Total other (expenses) income	`NonoperatingIncomeExpense`	$13.11K	USD	1 Quarter
Total other (expenses) income	`NonoperatingIncomeExpense`	$29.05K	USD	2 Qtrs
Total other (expenses) income	`NonoperatingIncomeExpense`	$1.64M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.81M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-11.12M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.69M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.12M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.79M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-10.67M	USD	1 Quarter
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.86	USD	2 Qtrs
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.50	USD	1 Quarter
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.73	USD	1 Quarter
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-1.45	USD	2 Qtrs
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	7.88M	shares	2 Qtrs
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	8.25M	shares	1 Quarter
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	15.32M	shares	1 Quarter
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	15.03M	shares	2 Qtrs

Cash Flow Statement 53 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-6.81M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-11.12M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.69M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.12M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.79M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-10.67M	USD	1 Quarter
Depreciation expense	`Depreciation`	$2.08K	USD	2 Qtrs
Depreciation expense	`Depreciation`	$2.16K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$12.34M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$798.15K	USD	2 Qtrs
Fair value of shares relinquished in litigation	`FairValueOfSharesRelinquished`	$-394.41K	USD	2 Qtrs
Realized loss on short-term investments	`RealizedGainLossOnInvestments`	$-158.80K	USD	2 Qtrs
Unrealized gain on short-term investments	`UnrealizedGainLossOnInvestments`	$287.03K	USD	2 Qtrs
Other receivable	`IncreaseDecreaseInOtherReceivables`	$176.98K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$6.09K	USD	2 Qtrs
Lease payment receivable	`IncreaseDecreaseInLeasingReceivables`	$-32.92K	USD	2 Qtrs
Lease payment receivable	`IncreaseDecreaseInLeasingReceivables`	$-35.78K	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-381.12K	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-183.33K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$565.47K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$442.51K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-72.69K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$536.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-8.38M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.68M	USD	2 Qtrs
Purchase of short-term investments	`PaymentsForProceedsFromInvestments`	$62.36M	USD	2 Qtrs
Sale of short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$22.39M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-39.97M	USD	2 Qtrs
Principal payments of notes payable	`ProceedsFromRepaymentsOfNotesPayable`	$-110.25K	USD	2 Qtrs
Principal payments of notes payable	`ProceedsFromRepaymentsOfNotesPayable`	$-114.74K	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfWarrants`	$12.58M	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfWarrants`	$19.86M	USD	2 Qtrs
Proceeds from options exercised for common stock	`OptionsExercisedForCommonStock`	$530.64K	USD	2 Qtrs
Proceeds from warrants exercised for common stock	`WarrantsExercisedForStock`	$5.62M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$12.47M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$25.89M	USD	2 Qtrs
Net (decrease)/increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-22.45M	USD	2 Qtrs
Net (decrease)/increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$6.79M	USD	2 Qtrs
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$9.22M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$2.43M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$13.82M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$36.28M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$9.22M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$2.43M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$13.82M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$36.28M	USD	Point-in-time
Income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Interest	`InterestPaidNet`	$954.00	USD	2 Qtrs
Interest	`InterestPaidNet`	$4.42K	USD	2 Qtrs
Cashless exercise of warrants for common stock	`CashlessExerciseOfWarrantsForCommonStock`	$36.00	USD	2 Qtrs
Cashless exercise of warrants for common stock	`CashlessExerciseOfWarrantsForCommonStock`	$25.00	USD	2 Qtrs
Notes payable issued in connection with directors and officers insurance policies	`IssuanceOfDebtInConnectionWithCompensationPolicy`	$364.20K	USD	2 Qtrs

Stockholders Equity 30 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$113.16M	USD	Point-in-time
Balance	`StockholdersEquity`	$132.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$1.43M	USD	Point-in-time
Balance	`StockholdersEquity`	$7.61M	USD	Point-in-time
Balance	`StockholdersEquity`	$115.68M	USD	Point-in-time
Balance	`StockholdersEquity`	$473.90K	USD	Point-in-time
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$394.69K	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$5.04M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$7.30M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$403.46K	USD	1 Quarter
Equity units issued for Cash	`StockIssuedDuringPeriodValueOther`	$1.73M	USD	1 Quarter
Equity units issued for Cash	`StockIssuedDuringPeriodValueOther`	$10.86M	USD	1 Quarter
Shares relinquished	`StockIssuedDuringPeriodSharesRelinquished`	$-394.41K	USD	1 Quarter
Warrant exercised for cash	`StockIssuedDuringWarrantExercisedForCash`	$3.04M	USD	1 Quarter
Warrant exercised for cash	`StockIssuedDuringWarrantExercisedForCash`	$2.58M	USD	1 Quarter
Options exercised	`StockIssuedDuringPeriodStockOptionsExercised`	$73.02K	USD	1 Quarter
Options exercised	`StockIssuedDuringPeriodStockOptionsExercised`	$457.62K	USD	1 Quarter
ATM offering, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$19.86M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.81M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-11.12M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.69M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.12M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.79M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-10.67M	USD	1 Quarter
Balance	`StockholdersEquity`	$113.16M	USD	Point-in-time
Balance	`StockholdersEquity`	$132.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$1.43M	USD	Point-in-time
Balance	`StockholdersEquity`	$7.61M	USD	Point-in-time
Balance	`StockholdersEquity`	$115.68M	USD	Point-in-time
Balance	`StockholdersEquity`	$473.90K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.